Work

A0688 Validation of the ePI-FAB score to predict residual disease following cooled focal laser ablation with ProFocalTM in prostate cancer

Year: 2026

Type: conference-abstract

Source: European Urology

DOI: 10.1016/s0302-2838(26)00739-6

Authors: Y. Bushati, H. McAuliffe, J. Kam, B. Canagasingham, A. Goolam, A. Hadley, M. Louie-Johnsun, M. Myint, D. Gillatt, M. Winter, M. Khadra, N. Mehan, M. Arianayagam, I. Thangasamy, C. Varol, N. Wang

Language: English

Topic: Prostate Cancer Diagnosis and Treatment

Subfield: Urology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7128808809

Cites:

Cited by:

Related to: 10